Chugai Pharmaceutical EPS - Earnings per Share 2020-2025 | CHGCY

Chugai Pharmaceutical earnings per share (EPS) for the twelve months ending March 31, 2025 was $0.52, a 43.31% decline year-over-year.

  • Chugai Pharmaceutical EPS for the quarter ending March 31, 2025 was $0.20, a 43.31% decline year-over-year.
  • Chugai Pharmaceutical 2024 annual EPS was $0.78, a 10.68% increase from 2023.
  • Chugai Pharmaceutical 2023 annual EPS was $0.7, a 19.86% decline from 2022.
  • Chugai Pharmaceutical 2022 annual EPS was $0.88, a 4.53% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Chugai Pharmaceutical EPS - Earnings per Share 2020-2025 | CHGCY

  • Chugai Pharmaceutical EPS for the quarter ending March 31, 2025 was $0.20, a 43.31% decline year-over-year.
  • Chugai Pharmaceutical 2024 annual EPS was $0.78, a 10.68% increase from 2023.
  • Chugai Pharmaceutical 2023 annual EPS was $0.7, a 19.86% decline from 2022.
  • Chugai Pharmaceutical 2022 annual EPS was $0.88, a 4.53% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.